Skip to main content

Advertisement

SpringerLink
Log in

Atopic Eczema

  • Invited Commentary
  • Published:
Current Allergy and Asthma Reports Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ring J: Allergy in Practice. Heidelberg: Springer, 2005.

    Google Scholar 

  2. Friedmann PS, Holden CA: Atopic dermatitis. In Rook’s Textbook of Dermatology, edn 7. Edited by Burns T,Breathnach S, Cox N, Griffiths C. Oxford: Blackwell, 2006.

    Google Scholar 

  3. Ring J, Krämer U, Schäfer T, Behrendt H: Why are allergies increasing? Curr Opinion Immunol 2001, 13:701–708.

    Article  CAS  Google Scholar 

  4. Wüthrich B: Epidemiology and natural history of atopic dermatitis. Allergy Clin Immunol Int 1996, 8:77–82.

    Google Scholar 

  5. Schultz-Larsen F: Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993, 28:719–723.

    Article  PubMed  CAS  Google Scholar 

  6. Cookson WO, Moffatt MF: The genetics of atopic dermatitis. Curr Opin Allergy Immunol 2002, 2:383–387.

    Article  Google Scholar 

  7. Leung DYM, Jain N, Leo HL: New concepts in the pathogenesis of atopic dermatitis. Curr Opin Immunol 2003, 15:634–638.

    Article  PubMed  CAS  Google Scholar 

  8. Tamura K, Suzuki M, Arakawa H, et al.: Linkage and association studies of STAT6 gene polymorphisms and allergic diseases. Int Arch Allergy Immunol 2003, 131:33–38.

    Article  PubMed  CAS  Google Scholar 

  9. Novak N, Kruse S, Kraft S, et al.: Dichotomic nature of atopic dermatitis reflected by combined analysis of monocyte immunophenotyping and single nucleotide polymorphisms of the interleukin-4/interleukin-13 receptor gene: the dichotomy of extrinsic and intrinsic atopic dermatitis. J Invest Dermatol 2002, 119:870–875.

    Article  PubMed  CAS  Google Scholar 

  10. Arkwright PD, Chase JM, Babbage S, et al.: Atopic dermatitis is associated with a low-producer transforming growth factor beta(1) cytokine genotype. J Allergy Clin Immunol 2001, 108:281–284.

    Article  PubMed  CAS  Google Scholar 

  11. Yagi R, Nagai H, Iigo Y, et al.: Development of atopic dermatitis-skin lesions in STAT6-deficient NC/Nga mice. J Immunol 2002, 168:2020–2027.

    PubMed  CAS  Google Scholar 

  12. Sandford AJ, Shirakawa T, Moffatt MF, et al.: Localisation of atopy and beta subunit of high-affinity IgE receptor (Fc epsilon RI) on chromosome 11q. Lancet 1993, 341:332–334.

    Article  PubMed  CAS  Google Scholar 

  13. Weidinger S, Klopp N, Wagenpfeil S, et al.: Association of a STAT 6 haplotype with elevated serum IgE levels in a population based cohort of white adults. J Med Genet 2004, 41:658–663.

    Article  PubMed  CAS  Google Scholar 

  14. Wiliams HC: Atopic dermatitis. N Engl J Med 2005, 352:2314–2324.

    Article  Google Scholar 

  15. Sampson HA, Albergo R: Comparison of results of skin tests, RAST, and double-blind, placebo-controlled food challenges in children with atopic dermatitis. J Allergy Clin Immunol 1984, 74:26–33.

    Article  PubMed  CAS  Google Scholar 

  16. Darsow U, Laifaoui J, Kerschenloh K, et al.: The prevalence of positive reactions in the atopy patch test with aeroallergens and food allergens in subjects with atopic eczema: a European multicenter study. Allergy 2004, 59:1318–1325.

    Article  PubMed  CAS  Google Scholar 

  17. Darsow U, Ring J: Airborne and dietary allergens in atopic eczema: a comprehensive review of diagnostic tests. Clin Exp Dermatol 2000, 25:544–551.

    Article  PubMed  CAS  Google Scholar 

  18. Möhrenschlager M, Schäfer T, Huss-Marp J, et al.: The course of eczema in children aged 5–7 years and its relation to atopy: differences between boys and girls. Br J Dermatol 2006, 154:505–513.

    Article  PubMed  Google Scholar 

  19. Abeck D, Burgdorf W, Cremer H: Common Skin Diseasesin Children. Darmstadt: Steinkopff, 2003.

    Google Scholar 

  20. Wollenberg A, Sharma S, von Bubnoff D, et al.: Topical tacrolimus (FK 506) leads to profound phenotypic alterations of epidermal antigen-presenting dendritic cells in atopic dermatitis. J Allergy Clin Immunol 2001, 107:519–525.

    Article  PubMed  CAS  Google Scholar 

  21. Panhans-Gross A, Novak N, Kraft S, Bieber T: Human epidermal Langerhans’ cells are targets for the immunosuppressive macrolide tacrolimus (FK506). J Allergy Clin Immunol 2001, 107:345–352.

    Article  PubMed  CAS  Google Scholar 

  22. Zuberbier T, Chong SU, Grunow K, et al.: The ascomycin macrolactam pimecrolimus (Elidel, SDZ ASM 981) is a potent inhibitor of mediator release from human dermal mast cells and peripheral blood basophils. J Allergy Clin Immunol 2001, 108:275–280.

    Article  PubMed  CAS  Google Scholar 

  23. Reitamo S, Van Leent EJ, Ho V, et al.: Efficacy and safety of tacrolimus ointment compared with that of hydrocortisone acetate ointment in children with atopic dermatitis. J Allergy Clin Immunol 2002, 109:539–546.

    Article  PubMed  CAS  Google Scholar 

  24. Reitamo S, Harper J, Bos JD, et al.: 0.03% tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized doubleblind controlled trial. Br J Dermatol 2004, 150:554–562.

    Article  PubMed  CAS  Google Scholar 

  25. Eichenfleld LF, Lucky AW, Boguniewicz M, et al.: Safety and Efficacy of pimecrolimus (ASM 981) cream 1% in the treatment of mild and moderate atopic dermatitis in children and adolescents. J Am Acad Dermatol 2002, 46:495–504.

    Article  Google Scholar 

  26. Center for Drug Evaluation and Research: Alert for healthcare professionals: pimecrolimus (marketed as Elidel). Rockville, MD: Food and Drug Administration; March 2005.

  27. Center for Drug Evaluation and Research: Alert for healthcare professionals: taccrolimus (marketed as Protopic). Rockville, MD: Food and Drug Administration; March 2005.

  28. Food and Drug Administration Pediatric Advisory Committee: February 15, 2005, Briefing Information. http://www.fda.gov/ohrms/dockets/ac/05/Briefing/2005-4089b2.htm. Accessed August 4, 2006.

  29. Allen BR, Lakhanpaul M, Morris A, et al.: Systemic exposure, tolerability and Efficacy of pimecrolimus cream 1% in atopic dermatitis patients. Arch Dis Child 2003, 88:969–973.

    Article  PubMed  CAS  Google Scholar 

  30. Bieber T, Cork M, Ellis C, et al.: Consensus statement on the safety profile of topical calcineurin inhibitors. Dermatology 2005, 211:77–78.

    Article  PubMed  CAS  Google Scholar 

  31. Mallon E, Powell S, Bridgman A: Wet-wrap dressings for the treatment of atopic eczema in the community. J Dermatol Treat 1994, 5:97–98.

    Google Scholar 

  32. Keane FM, Munn SE, du Vivier AWP, et al.: Analysis of Chinese herbal creams prescribed for dermatological conditions. BMJ 1999, 318:563–564.

    PubMed  CAS  Google Scholar 

  33. McMenamy CJ, Katz RC, Gipson M: Treatment of eczema by EMG biofeedback and relaxation training: a multiple baseline analysis. J Behav Ther Exp Psychiatry 1988, 19:221–227.

    Article  PubMed  CAS  Google Scholar 

  34. Schachner L, Field T, Hernandez-Reif M, et al.: Atopic dermatitis symptoms decreased in children following massage therapy. Ped Dermatol 1998, 15:390–395.

    Article  CAS  Google Scholar 

  35. Senser C, Habermüller M, Revenstorf D: Hypnotherapie bei atopischer Dermatitis. Akt Dermatol 2004, 30:103–108.

    Article  Google Scholar 

  36. Staab D, Diepgen TL, Fartasch M, et al.: Age-related, structured educational programmes for the management of atopic dermatitis in children and adolescents: multicentre, randomised controlled trial. BMJ 2006, 332:933–938.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Environmental Dermatology and Allergy GSF/TUM, Department of Dermatology and Allergy Biederstein, Technical University of Munich, Biedersteiner Strasse 29, D-80802, Munich, Germany

    Matthias Möhrenschlager MD

Authors
  1. Matthias Möhrenschlager MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Johannes Ring MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Matthias Möhrenschlager MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Möhrenschlager, M., Ring, J. Atopic Eczema. Curr Allergy Asthma Rep 6, 445–447 (2006). https://doi.org/10.1007/s11882-006-0016-5

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11882-006-0016-5

Keywords

Search

Navigation